• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶烷二萜类化合物作为开发ArnT介导的黏菌素耐药抑制剂的关键平台

-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors.

作者信息

Quaglio Deborah, Mangoni Maria Luisa, Stefanelli Roberta, Corradi Silvia, Casciaro Bruno, Vergine Valeria, Lucantoni Federica, Cavinato Luca, Cammarone Silvia, Loffredo Maria Rosa, Cappiello Floriana, Calcaterra Andrea, Erazo Silvia, Ghirga Francesca, Mori Mattia, Imperi Francesco, Ascenzioni Fiorentina, Botta Bruno

机构信息

Department of Chemistry and Technology of Drugs, "Department of Excellence 2018-2022", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.

Laboratory Affiliated to Pasteur Italia-Fondazione Cenci Bolognetti, Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.

出版信息

J Org Chem. 2020 Aug 21;85(16):10891-10901. doi: 10.1021/acs.joc.0c01459. Epub 2020 Aug 10.

DOI:10.1021/acs.joc.0c01459
PMID:32806095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009527/
Abstract

Colistin is a last-resort antibiotic for the treatment of multidrug resistant Gram-negative bacterial infections. Recently, a natural -beyerene diterpene was identified as a promising inhibitor of the enzyme responsible for colistin resistance mediated by lipid A aminoarabinosylation in Gram-negative bacteria, namely, ArnT (undecaprenyl phosphate-alpha-4-amino-4-deoxy-l-arabinose arabinosyl transferase). Here, semisynthetic analogues of hit were designed, synthetized, and tested against colistin-resistant strains including clinical isolates to exploit the versatility of the diterpene scaffold. Microbiological assays coupled with molecular modeling indicated that for a more efficient colistin adjuvant activity, likely resulting from inhibition of the ArnT activity by the selected compounds and therefore from their interaction with the catalytic site of ArnT, an -beyerane scaffold is required along with an oxalate-like group at C-18/C-19 or a sugar residue at C-19 to resemble L-Ara4N. The -beyerane skeleton is identified for the first time as a privileged scaffold for further cost-effective development of valuable colistin resistance inhibitors.

摘要

黏菌素是治疗多重耐药革兰氏阴性菌感染的最后一道抗生素防线。最近,一种天然的贝壳杉烯二萜被鉴定为一种有前景的酶抑制剂,该酶负责革兰氏阴性菌中由脂多糖氨基阿拉伯糖基化介导的黏菌素耐药性,即ArnT(十一异戊二烯磷酸-α-4-氨基-4-脱氧-L-阿拉伯糖阿拉伯糖基转移酶)。在此,设计、合成了该命中化合物的半合成类似物,并针对包括临床分离株在内的耐黏菌素菌株进行了测试,以利用二萜支架的多功能性。微生物学测定与分子建模表明,为了获得更有效的黏菌素佐剂活性,这可能是由于所选化合物抑制了ArnT活性,进而与ArnT的催化位点相互作用导致的,需要一个贝壳杉烷支架以及在C-18/C-19处的类似草酸盐基团或在C-19处的糖残基以类似L-Ara4N。贝壳杉烷骨架首次被确定为一种有优势的支架,可用于进一步经济高效地开发有价值的黏菌素耐药性抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/f9e9c7eb683e/jo0c01459_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/499b03522ebf/jo0c01459_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/2da5747f9de2/jo0c01459_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/8fb0a3236d3c/jo0c01459_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/d8756fecb7e7/jo0c01459_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/3ffe89aeca91/jo0c01459_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/7d65e4e43207/jo0c01459_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/74973a81cbe7/jo0c01459_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/23340132ab27/jo0c01459_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/f9e9c7eb683e/jo0c01459_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/499b03522ebf/jo0c01459_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/2da5747f9de2/jo0c01459_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/8fb0a3236d3c/jo0c01459_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/d8756fecb7e7/jo0c01459_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/3ffe89aeca91/jo0c01459_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/7d65e4e43207/jo0c01459_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/74973a81cbe7/jo0c01459_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/23340132ab27/jo0c01459_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/992d/8009527/f9e9c7eb683e/jo0c01459_0007.jpg

相似文献

1
-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors.贝叶烷二萜类化合物作为开发ArnT介导的黏菌素耐药抑制剂的关键平台
J Org Chem. 2020 Aug 21;85(16):10891-10901. doi: 10.1021/acs.joc.0c01459. Epub 2020 Aug 10.
2
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors.一种新型多粘菌素助剂,通过虚拟筛选 ArnT 抑制剂发现。
J Antimicrob Chemother. 2020 Sep 1;75(9):2564-2572. doi: 10.1093/jac/dkaa200.
3
Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in -Negative Escherichia coli Clinical Isolates, Including Major Multidrug-Resistant Lineages O25b:H4-ST131-30Rx and Non-x.新型氨基酸改变在 PmrA 或 PmrB 中对 -阴性大肠杆菌临床分离株中多粘菌素耐药性的贡献,包括主要的多药耐药谱系 O25b:H4-ST131-30Rx 和非-x。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00864-18. Print 2018 Sep.
4
Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.脂阿拉伯甘露糖胺化对于铜绿假单胞菌对多黏菌素耐药性的发展至关重要。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01820-17. Print 2018 Mar.
5
Effect of lipid A aminoarabinosylation on Pseudomonas aeruginosa colistin resistance and fitness.脂阿拉伯甘露糖胺化对铜绿假单胞菌对黏菌素耐药性和适应性的影响。
Int J Antimicrob Agents. 2020 May;55(5):105957. doi: 10.1016/j.ijantimicag.2020.105957. Epub 2020 Apr 8.
6
The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.外排泵 MexXY/OprM 有助于铜绿假单胞菌对多粘菌素的耐受性和获得性耐药性。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02033-19.
7
Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.中国温州分离的铜绿假单胞菌对黏菌素的耐药性和异质性耐药。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00556-19. Print 2019 Oct.
8
Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.铜绿假单胞菌中与arnB无关的黏菌素耐药性。
J Med Microbiol. 2017 Jun;66(6):833-841. doi: 10.1099/jmm.0.000456.
9
Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.I 型信号肽酶抑制剂 MD3 单独及联合多粘菌素对多重耐药革兰氏阴性菌的活性。
J Antimicrob Chemother. 2014 Dec;69(12):3236-43. doi: 10.1093/jac/dku309. Epub 2014 Aug 18.
10
Rapid and Consistent Evolution of Colistin Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa during Morbidostat Culture.在密集药物抗性铜绿假单胞菌的病态恒化培养中,多粘菌素耐药性迅速而一致的演变。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00043-17. Print 2017 Sep.

引用本文的文献

1
Biological Evaluation and Computational Modelling Studies on -acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents.酰腙和2,5-二取代-1,3,4-恶二唑衍生物作为无毒抗菌剂的生物学评价与计算建模研究
Curr Pharm Des. 2025;31(32):2611-2624. doi: 10.2174/0113816128361524250131110036.
2
Advances in Development of Novel Therapeutic Strategies against Multi-Drug Resistant .针对多重耐药的新型治疗策略的发展进展
Antibiotics (Basel). 2024 Jan 25;13(2):119. doi: 10.3390/antibiotics13020119.
3
Untying the anchor for the lipopolysaccharide: lipid A structural modification systems offer diagnostic and therapeutic options to tackle polymyxin resistance.

本文引用的文献

1
The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections.植物源萜类化合物对抗生素耐药性感染的重新评估
Antibiotics (Basel). 2020 Jun 13;9(6):325. doi: 10.3390/antibiotics9060325.
2
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors.一种新型多粘菌素助剂,通过虚拟筛选 ArnT 抑制剂发现。
J Antimicrob Chemother. 2020 Sep 1;75(9):2564-2572. doi: 10.1093/jac/dkaa200.
3
Structural Elucidation and Antimicrobial Characterization of Novel Diterpenoids from var. .来自[具体植物名称]变种的新型二萜类化合物的结构解析与抗菌特性研究
解开脂多糖的束缚:脂质 A 结构修饰系统为解决多粘菌素耐药性提供了诊断和治疗选择。
Arh Hig Rada Toksikol. 2023 Sep 30;74(3):145-166. doi: 10.2478/aiht-2023-74-3717. eCollection 2023 Sep 1.
4
Selection of Natural Compounds with HMGA-Interfering Activities and Cancer Cell Cytotoxicity.具有HMGA干扰活性和癌细胞细胞毒性的天然化合物的筛选。
ACS Omega. 2023 Aug 28;8(36):32424-32431. doi: 10.1021/acsomega.3c02043. eCollection 2023 Sep 12.
5
Regulatory Landscape of the Phosphoethanolamine Transferase Gene in the Context of Colistin Resistance.在黏菌素耐药背景下磷酸乙醇胺转移酶基因的调控格局
Antibiotics (Basel). 2023 Jan 18;12(2):200. doi: 10.3390/antibiotics12020200.
6
Biologically Active Diterpenoids in the Genus-A Review.生物活性二萜类化合物在属中的研究进展-综述
Int J Mol Sci. 2022 Sep 20;23(19):11001. doi: 10.3390/ijms231911001.
7
Diterpenoid Constituents of and Evaluation of Their Antimicrobial Activity.贯叶金丝桃中二萜类成分的研究及其抗菌活性评价。
J Nat Prod. 2022 Jul 22;85(7):1667-1680. doi: 10.1021/acs.jnatprod.1c01093. Epub 2022 Jun 24.
8
Antimicrobial Diterpenes: Recent Development From Natural Sources.抗微生物二萜类化合物:天然来源的最新进展
Front Pharmacol. 2022 Feb 28;12:820312. doi: 10.3389/fphar.2021.820312. eCollection 2021.
9
The Triprenylated Anthranoid Ferruginin A, a Promising Scaffold for the Development of Novel Antibiotics against Gram-Positive Bacteria.三异戊烯基蒽醌铁红菌素A,一种开发新型抗革兰氏阳性菌抗生素的有前景的骨架。
Antibiotics (Basel). 2022 Jan 11;11(1):84. doi: 10.3390/antibiotics11010084.
10
How to Combat Gram-Negative Bacteria Using Antimicrobial Peptides: A Challenge or an Unattainable Goal?如何使用抗菌肽对抗革兰氏阴性菌:一项挑战还是一个无法实现的目标?
Antibiotics (Basel). 2021 Dec 7;10(12):1499. doi: 10.3390/antibiotics10121499.
ACS Med Chem Lett. 2020 Jan 30;11(5):760-765. doi: 10.1021/acsmedchemlett.9b00605. eCollection 2020 May 14.
4
Effect of lipid A aminoarabinosylation on Pseudomonas aeruginosa colistin resistance and fitness.脂阿拉伯甘露糖胺化对铜绿假单胞菌对黏菌素耐药性和适应性的影响。
Int J Antimicrob Agents. 2020 May;55(5):105957. doi: 10.1016/j.ijantimicag.2020.105957. Epub 2020 Apr 8.
5
Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains.探讨世界卫生组织优先重点细菌菌株的抗微生物药物耐药性特征。
BMC Microbiol. 2019 Dec 23;19(1):303. doi: 10.1186/s12866-019-1687-0.
6
Cystic Fibrosis Lung Disease: An Overview.囊性纤维化肺病:概述。
Respir Care. 2020 Feb;65(2):233-251. doi: 10.4187/respcare.06697. Epub 2019 Nov 26.
7
Structure-Function Studies on IMD-0354 Identifies Highly Active Colistin Adjuvants.结构-功能研究表明 IMD-0354 是一种高活性的黏菌素佐剂。
ChemMedChem. 2020 Jan 17;15(2):210-218. doi: 10.1002/cmdc.201900560. Epub 2019 Dec 4.
8
Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of -Induced Infections.黑藤宁作为一种新的潜在抗菌生物碱,可用于治疗 - 诱导的感染。
Toxins (Basel). 2019 Sep 1;11(9):511. doi: 10.3390/toxins11090511.
9
Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria.将真核激酶抑制剂重新用作革兰氏阴性菌中多粘菌素的佐剂
ACS Infect Dis. 2019 Oct 11;5(10):1764-1771. doi: 10.1021/acsinfecdis.9b00212. Epub 2019 Sep 4.
10
Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.色胺衍生物使耐多粘菌素的革兰氏阴性菌失去抗药性。
Bioorg Med Chem. 2019 May 1;27(9):1776-1788. doi: 10.1016/j.bmc.2019.03.019. Epub 2019 Mar 8.